Iwatsubo, Takeshi

Publication Detail

The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.

Multiple effects of aspartate mutant presenilin 1 on the processing and trafficking of amyloid precursor protein.

S H Kim; J Y Leem; J J Lah; H H Slunt; A I Levey; G Thinakaran; S S Sisodia (Profiled Author: Sisodia, Sangram S)

Department of Neurobiology, The University of Chicago, Chicago, Illinois 60637, USA.
The Journal of biological chemistry 2001;276(46):43343-50.

PS1 deficiency and expression of PS1 with substitutions of two conserved transmembrane aspartate residues ("PS1 aspartate variants") leads to the reduction of Abeta peptide secretion and the accumulation of amyloid precursor protein (APP) C-terminal fragments. To define the nature of the "dominant negative" effect of the PS1 aspartate variants, we stably expressed PS1 harboring aspartate to alanine substitutions at codons 257 (D257A) or 385 (D385A), singly or in combination (D257A/D385A), in mouse neuroblastoma, N2a cells. Expression of the PS1 aspartate variants resulted in marked accumulation of intracellular and cell surface APP C-terminal fragments. While expression of the D385A PS1 variant reduced the levels of secreted Abeta peptides, we now show that neither the PS1 D257A nor D257A/D385A variants impair Abeta production. Surprisingly, the stability of both immature and mature forms of APP is dramatically elevated in cells expressing PS1 aspartate variants, commensurate with an increase in the cell surface levels of APP. These findings lead us to conclude that the stability and trafficking of APP can be profoundly modulated by coexpression of PS1 with mutations at aspartate 257 and aspartate 385.

2 Originating Grant

• 1.

  PRICE, DONALD L

  PRESENILINS IN MODELS OF FAMILIAL ALZHEIMERS DISEASE

  12 March 1997 - 28 February 2002

  NATIONAL INSTITUTE ON AGING

  Total Funding: $ 2,001,677

• 2.

  Sisodia, Sangram S

  PRESENILINS IN MODELS OF FAMILIAL ALZHEIMERS DISEASE

  Total Funding: $ 1,966,810

Scientific Context

This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.